Back to search

Ireland· IE-PA-EU/1/22/1703/001

Pluvicto 1000 MBq/mL solution for injection/infusion

A lutetium (177lu) vipivotide tetraxetan product containing lutetium (177lu) vipivotide tetraxetan, registered in Ireland by Novartis Europharm Limited. The same ATC class is registered in 9 of our 19 countries.

ATC V10XX05

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedPluvicto 1000 MBq/mL solution for inj…ATCV10XX05REGISTER NO.IE-PA-EU/1/22/1703/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Lutetium (177lu) vipivotide tetraxetan is registered in 9 of 19 countries.

Countries holding a registration under ATC V10XX05 (lutetium (177lu) vipivotide tetraxetan), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 5 of them publish a price we can compare per daily dose

Lutetium (177lu) vipivotide tetraxetan · ATC V10XX05

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Lutetium (177Lu) vipivotide tetraxetan
Manufacturer
Novartis Europharm Limited
Country
Ireland (IE)
ATC code
V10XX05
ATC class
Lutetium (177Lu) vipivotide tetraxetan
Defined daily dose
176 MBq, P
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/22/1703/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lutetium (177lu) vipivotide tetraxetan in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lutetium (177lu) vipivotide tetraxetan products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Pluvicto
  • Liechtenstein · Pluvicto
  • Norway · Pluvicto

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f58aee3f-711b-41bc-96b6-2eea8b790815
GET /v1/drugs/f58aee3f-711b-41bc-96b6-2eea8b790815?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection/infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "V10XX",
    "V10XX05"
  ],
  "strength": null,
  "pa_number": "EU/1/22/1703/001",
  "substances": [
    "Lutetium (177Lu) vipivotide tetraxetan"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "09/12/2022",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about lutetium (177lu) vipivotide tetraxetan.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.